This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chen, G. Articles by Chinnaiyan, A. M. Search for Related Content PubMed PubMed Citation Articles by Chen, G. Articles by Chinnaiyan, A. M.

Autoantibody Profiles Reveal Ubiquilin 1 as a Humoral Immune Response Target in Lung Adenocarcinoma

Departments of ¹ Surgery, ² Pathology, ³ Bioinformatics, ⁴ Biostatistics, and ⁵ Urology and ⁶ Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan; and ⁷ University of Pittsburgh Cancer Institute/Hillman Cancer Center, Pittsburgh, Pennsylvania

Requests for reprints: Arul M. Chinnaiyan, Department of Pathology and Urology, University of Michigan Medical School, 1301 Catherine Street, MSI 4237, University of Michigan, Ann Arbor, MI 48109-0602. Phone: 734-647-8153; Fax: 734-936-7361; E-mail: arul{at}umich.edu and David G. Beer, Department of Surgery, University of Michigan Medical School, 1301 Catherine Street, MSRB II B560, University of Michigan, Ann Arbor, MI 48109. Phone: 734-763-0325; Fax: 734-763-0323; E-mail: dgbeer{at}umich.edu.

There is considerable evidence that the presence of cancer can elicit a humoral immune response to specific proteins in the host, and these resulting autoantibodies may have potential as noninvasive biomarkers. To characterize the autoantibody repertoire present in the sera of patients with lung adenocarcinoma, we developed a high-density peptide microarray derived from biopanning a lung cancer phage display library. Using a 2,304-element microarray, we interrogated a total of 250 sera from Michigan lung cancer patients and noncancer controls to develop an "autoantibody profile" of lung adenocarcinoma. A set of 22 discriminating peptides derived from a training set of 125 serum samples from lung adenocarcinoma patients and control subjects was found to predict cancer status with 85% sensitivity and 86% specificity in an independent test set of 125 sera. Sequencing of the immunoreactive phage-peptide clones identified candidate humoral immune response targets in lung adenocarcinoma, including ubiquilin 1, a protein that regulates the degradation of several ubiquitin-dependent proteasome substrates. An independent validation set of 122 serum samples from Pittsburgh was examined using two overlapping clones of ubiquilin 1 that showed 0.79 and 0.74 of the area under the receiver operating characteristics curve, respectively. Significantly increased levels of both ubiquilin 1 mRNA and protein, as well as reduced levels of the phosphorylated form of this protein, were detected in lung tumors. Immunofluorescence using anti–ubiquilin 1 antibodies confirmed intracellular expression within tumors cells. These studies indicate that autoantibody profiles, as well as individual candidates, may be useful for the noninvasive detection of lung adenocarcinoma. [Cancer Res 2007;67(7):3461–7]

This article has been cited by other articles:

				N. Ludwig, A. Keller, N. Comtesse, S. Rheinheimer, C. Pallasch, U. Fischer, K. Fassbender, W. I. Steudel, H.-P. Lenhof, and E. Meese Pattern of Serum Autoantibodies Allows Accurate Distinction between a Tumor and Pathologies of the Same Organ Clin. Cancer Res., August 1, 2008; 14(15): 4767 - 4774. [Abstract] [Full Text] [PDF]

				Y. Ran, H. Hu, Z. Zhou, L. Yu, L. Sun, J. Pan, J. Liu, and Z. Yang Profiling Tumor-Associated Autoantibodies for the Detection of Colon Cancer Clin. Cancer Res., May 1, 2008; 14(9): 2696 - 2700. [Abstract] [Full Text] [PDF]

				A. Li, Z. Xie, Y. Dong, K. M. McKay, M. L. McKee, and R. E. Tanzi Isolation and characterization of the Drosophila ubiquilin ortholog dUbqln: in vivo interaction with early-onset Alzheimer disease genes Hum. Mol. Genet., November 1, 2007; 16(21): 2626 - 2639. [Abstract] [Full Text] [PDF]